Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tricholoma matsutake extract is a natural product derived from the fruiting body or mycelium of the Tricholoma matsutake mushroom, also known as the pine mushroom. The extract contains bioactive compounds such as polysaccharides (notably β-glucan), triterpenoids, and phenolic compounds. It has demonstrated antioxidant, immunomodulatory, anti-inflammatory, and antitumor properties in preclinical studies. Mechanistically, it inhibits elastase activity and matrix metalloproteinases (MMP-1 and MMP-3), increases tissue inhibitor of metalloproteinases (TIMP-1) expression in skin fibroblasts[1], induces apoptosis via caspase-dependent mitochondrial pathways in cancer cells[2][8], and acts as a tyrosinase inhibitor for skin whitening[6]. Traditionally used in East Asian medicine to support immune function and digestion[4], it is now commonly found in anti-aging skincare products for its ability to improve complexion and reduce wrinkles[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tricholoma matsutake extract.